FDA to sidestep advisers on approval for expanding COVID booster shot eligibility
WASHINGTON — The Food and Drug Administration's committee of outside experts is not planning to meet to discuss the data on Pfizer's request for authorization of boosters-for-all, which federal officials are expected to greenlight this week, ...
from Google Alert - Business https://ift.tt/3wURvvn
WASHINGTON — The Food and Drug Administration's committee of outside experts is not planning to meet to discuss the data on Pfizer's request for authorization of boosters-for-all, which federal officials are expected to greenlight this week, ... https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/3wURvvn
WASHINGTON — The Food and Drug Administration's committee of outside experts is not planning to meet to discuss the data on Pfizer's request for authorization of boosters-for-all, which federal officials are expected to greenlight this week, ... https://ift.tt/eA8V8J
Comments
Post a Comment